Evidence map›Paper›PMID 19515285›Full record

ArticleCurrent neurology and neuroscience reports2009

Epilepsy in the developing world.

Arturo Carpio, W Allen Hauser

Abstract read
PubMed Publisher
In one paragraph

Article in Current neurology and neuroscience reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Integrated virtual screening, molecular modeling and machine learning approaches revealed potential natural inhibitors for epilepsy.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Incidence of epilepsy in Ferrara, Italy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. A review of the epidemiology of temporal lobe epilepsy.Epilepsy research and treatment · 2012
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Arturo CarpioResearch Institute, School of Medicine, University of Cuenca, Ciudadela Universitaria, Cuenca, Ecuador. arturo.carpio@ucuenca.edu.ec
W Allen Hauser
University of Cuenca · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing countries (DCs) and developed countries have geographic, economic, and social differences. The prevalence and incidence of epilepsy are higher in DCs than in developed countries. However, within DCs, given the high incidence of epilepsy, the prevalence is relatively low, which may be due to high mortality for people with epilepsy (PWE). Neurocysticercosis is one of the main causes of symptomatic epilepsy in many DCs. Prognosis in DCs seems similar to that in developed countries. Because phenobarbital and phenytoin are available and inexpensive, they are the drugs most often used in DCs. The cost of newer antiepileptic drugs and the limited availability of resources for epilepsy care in DCs mean that care for PWE in DCs is marginalized and that many people receive no pharmacologic treatment. The most cost-effective way to decrease the treatment gap in DCs would be to deliver the epilepsy services through primary health care.

Indexed as

Developing CountriesAnticonvulsantsBrainClinical Trials as TopicDelivery of Health CareDeveloped CountriesEpilepsyHealth Care CostsHumansIncidenceNeurocysticercosisPrevalencePrognosisRecurrenceRisk FactorsSeizuresAnticonvulsants

Identifiers

PMID19515285
OpenAlexW2095211552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.